PegBio Co., Ltd. — Board/Management Information 2012

Mar 30, 2012

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [114 x 25] intentionally omitted <==

==> picture [114 x 25] intentionally omitted <==

BEIJING YU SHENG TANG PHARMACEUTICAL GROUP LIMITED

北京御生堂藥業集團有限公司 *

(Incorporated in Bermuda with limited liability)

(Stock Code: 1141)

(I) CHANGE OF CHAIRMAN OF THE REMUNERATION COMMITTEE AND

(II) FORMATION OF NOMINATION COMMITTEE

The Board announces that Mr. Sue Ka Lok has ceased to act as chairman of the Remuneration Committee but remains as a member of the Remuneration Committee, and Mr. Weng Yixiang has been appointed as chairman of the Remuneration Committee with effect from 30 March 2012.

The Board further announces that the Nomination Committee comprising Mr. Lu Xinsheng as chairman and Mr. Sue Ka Lok, Mr. Wong Kwok Tai and Mr. Weng Yixiang as members has been established by the Board with written terms of reference with effect from 30 March 2012.

(I) CHANGE OF CHAIRMAN OF REMUNERATION COMMITTEE

The Board of Directors (the “Board”) of Beijing Yu Sheng Tang Pharmaceutical Group Limited (the “Company”) announces that Mr. Sue Ka Lok has ceased to act as chairman of the remuneration committee of the Company (the “Remuneration Committee”) but remains as a member of the Remuneration Committee, and Mr. Weng Yixiang has been appointed as chairman of the Remuneration Committee with effect from 30 March 2012.

(II) FORMATION OF NOMINATION COMMITTEE

The Board further announces that a nomination committee of the Company (the “Nomination Committee”) comprising Mr. Lu Xinsheng as chairman and Mr. Sue Ka Lok, Mr. Wong Kwok Tai and Mr. Weng Yixiang as members has been established by the Board with written terms of reference with effect from 30 March 2012.

* For identification purpose only

1

By Order of the Board Sue Ka Lok

Chief Executive Officer

Hong Kong, 30 March 2012

As at the date of this announcement, the Board comprises Mr. Suen Cho Hung, Paul (Chairman), Mr. Sue Ka Lok (Chief Executive Officer), Mr. Bai Jianjiang and Ms. Lee Chun Yeung, Catherine as Executive Directors and Mr. Wong Kwok Tai, Mr. Weng Yixiang and Mr. Lu Xinsheng as Independent Non-executive Directors.

2